Stephen Baxter
Stock Analyst at Wells Fargo
(3.32)
# 1,040
Out of 5,113 analysts
243
Total ratings
49.37%
Success rate
2.45%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAH Cardinal Health | Maintains: Overweight | $221 → $237 | $210.93 | +12.36% | 10 | Jan 15, 2026 | |
| MDLN Medline | Initiates: Equal-Weight | $42 | $44.84 | -6.33% | 1 | Jan 12, 2026 | |
| MOH Molina Healthcare | Maintains: Overweight | $165 → $208 | $201.05 | +3.46% | 22 | Jan 7, 2026 | |
| ELV Elevance Health | Maintains: Overweight | $403 → $424 | $376.93 | +12.49% | 15 | Jan 7, 2026 | |
| CNC Centene | Maintains: Equal-Weight | $35 → $43 | $46.28 | -7.09% | 25 | Jan 7, 2026 | |
| PNTG The Pennant Group | Maintains: Overweight | $31 → $38 | $30.56 | +24.37% | 4 | Jan 7, 2026 | |
| THC Tenet Healthcare | Maintains: Overweight | $252 → $229 | $189.92 | +20.58% | 17 | Jan 7, 2026 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $431 → $452 | $472.38 | -4.31% | 18 | Jan 7, 2026 | |
| CYH Community Health Systems | Maintains: Underweight | $3 → $2 | $3.20 | -37.50% | 12 | Jan 7, 2026 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $39 → $43 | $40.09 | +7.26% | 8 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $290 | $263.63 | +10.00% | 13 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $259 → $235 | $206.10 | +14.02% | 17 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $14 → $11 | $15.70 | -29.94% | 13 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $102 | $83.87 | +21.62% | 16 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $354 → $405 | $355.51 | +13.92% | 5 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $816 → $914 | $826.62 | +10.57% | 9 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1.5 → $1 | $0.95 | +5.39% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $354 → $300 | $280.41 | +6.99% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $267 → $400 | $351.64 | +13.75% | 15 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $6.29 | +138.47% | 3 | Apr 29, 2024 |
Cardinal Health
Jan 15, 2026
Maintains: Overweight
Price Target: $221 → $237
Current: $210.93
Upside: +12.36%
Medline
Jan 12, 2026
Initiates: Equal-Weight
Price Target: $42
Current: $44.84
Upside: -6.33%
Molina Healthcare
Jan 7, 2026
Maintains: Overweight
Price Target: $165 → $208
Current: $201.05
Upside: +3.46%
Elevance Health
Jan 7, 2026
Maintains: Overweight
Price Target: $403 → $424
Current: $376.93
Upside: +12.49%
Centene
Jan 7, 2026
Maintains: Equal-Weight
Price Target: $35 → $43
Current: $46.28
Upside: -7.09%
The Pennant Group
Jan 7, 2026
Maintains: Overweight
Price Target: $31 → $38
Current: $30.56
Upside: +24.37%
Tenet Healthcare
Jan 7, 2026
Maintains: Overweight
Price Target: $252 → $229
Current: $189.92
Upside: +20.58%
HCA Healthcare
Jan 7, 2026
Maintains: Equal-Weight
Price Target: $431 → $452
Current: $472.38
Upside: -4.31%
Community Health Systems
Jan 7, 2026
Maintains: Underweight
Price Target: $3 → $2
Current: $3.20
Upside: -37.50%
BrightSpring Health Services
Jan 7, 2026
Maintains: Overweight
Price Target: $39 → $43
Current: $40.09
Upside: +7.26%
Jan 7, 2026
Downgrades: Equal-Weight
Price Target: $290
Current: $263.63
Upside: +10.00%
Jan 7, 2026
Downgrades: Equal-Weight
Price Target: $259 → $235
Current: $206.10
Upside: +14.02%
Nov 13, 2025
Maintains: Underweight
Price Target: $14 → $11
Current: $15.70
Upside: -29.94%
Nov 13, 2025
Maintains: Overweight
Price Target: $103 → $102
Current: $83.87
Upside: +21.62%
Nov 11, 2025
Maintains: Overweight
Price Target: $354 → $405
Current: $355.51
Upside: +13.92%
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $816 → $914
Current: $826.62
Upside: +10.57%
Nov 5, 2025
Maintains: Overweight
Price Target: $1.5 → $1
Current: $0.95
Upside: +5.39%
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $354 → $300
Current: $280.41
Upside: +6.99%
Oct 7, 2025
Maintains: Overweight
Price Target: $267 → $400
Current: $351.64
Upside: +13.75%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $6.29
Upside: +138.47%